Axelle Pintiaux

No ORCID on file · 6 papers in corpus · active 2009-2024

Study types

  • article 2
  • review 2
  • case-report 1
  • editorial 1

Condition tags

  • endometriosis 1
  • adenomyosis 1
case-report 2024
Revue medicale de Liege

Selective progesterone receptor modulators (SPRMs) are synthetic steroid compounds that interact with the progesterone receptor, inducing various agonist, antagonist or mixed responses. First identified with mifepristone, they are now repre…

review 2015
·doi:10.3109/13625187.2015.1050091

OBJECTIVE: Since its introduction 50 years ago, the contraceptive pill has continuously evolved to decrease the risk of venous thromboembolism (VTE) associated with its use. An increased risk of VTE still remains, however. Other concerns, s…

review 2012
Molecular and cellular endocrinology ·doi:10.1016/j.mce.2012.02.021
article 2010

En contraception orale estroprogestative, la reduction drastique, aussi bien des doses d'ethinyl-estradiol que des progestatifs androgeniques derives de la 19 NOR testosterone, a permis de diminuer moderement l'impact metabolique et vascula…

article 2010

In combined oral contraception (OC), a drastic reduction of both ethinylestradiol and androgenic progestins mostly derived from 19 NOR testosterone, allowed to moderately reduce the adverse impact of classical combined pills on metabolism a…

editorial 2009
·doi:10.1080/09513590802531120

Selective progesterone receptor modulators (SPRM) represent a new class of synthetic steroids, which can interact with the progesterone receptor (PR) and can exert agonist, antagonist or mixed effects on various progesterone target tissues …